Method for the augmentation of substance abuse therapies using cannabinoid formulations
OwnerMax Hammondinventor
Life of this patent
Estimating the term…
Abstract
This disclosure relates to the use of preparations of CBDA to reduce the instances of relapse during addiction recovery and to increase its bioavailability using cyclodextrin. Other preparations are disclosed wherein decarboxylated cannabinoids and specific species of THC are also effective. The preparations may be used alone, to augment treatment following suboxone or methadone therapies, of utilized post-treatment.
Claims13
A method of reducing instances of relapse in substance abuse disorder therapy patients to comprising using an orally administered compounded cannabinoid formulation to alleviate withdrawal symptoms, said cannabinoid formulation containing at least 50% (mass) CBDA and is compounded with an agent to increase bioavailability of non-polar formulation constituents.
A method of restoring and maintaining homeostasis via the endocannabinoid system comprising using an orally administered compounded cannabinoid formulation, said cannabinoid formulation containing at least 50% (mass) CBDA and is compounded with an agent to increase bioavailability of non-polar formulation constituents.
Dependencies are inferred from the claim text.